| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of a Pharmacokinetic Interaction Between Entecavir and Adefovir
|
Bifano, Marc
|
|
2007
|
|
10 |
p. 1327-1334
|
artikel
|
| 2 |
Acetaminophen Toxicity
|
Madan, P. L.
|
|
1977
|
|
10 |
p. 555-560
|
artikel
|
| 3 |
A Comparison of the Analgesic Effect of Intramuscular Nefopam and Morphine in Patients with Postoperative Pain
|
Beaver, William T.
|
|
1977
|
|
10 |
p. 579-591
|
artikel
|
| 4 |
A Contract Research Organization's Response to the New FDA Guidances for Bioequivalence/Bioavailability Studies for Orally Administered Drug Products
|
Kimanani, Ebi
|
|
2000
|
|
10 |
p. 1102-1108
|
artikel
|
| 5 |
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Ebastine 20 mg Once Daily Given with and without Food in the Treatment of Seasonal Allergic Rhinitis
|
Hampel, Frank
|
|
2002
|
|
10 |
p. 1097-1104
|
artikel
|
| 6 |
Adverse Drug Reactions: A Review of Relevant Factors
|
Ajayi, Funmilayo O.
|
|
2000
|
|
10 |
p. 1093-1101
|
artikel
|
| 7 |
Aging and Clinical Pharmacology: Implications for Antidepressants
|
Lotrich, Francis E.
|
|
2005
|
|
10 |
p. 1106-1122
|
artikel
|
| 8 |
Altered Pharmacokinetics of Indinavir by a Novel Nonnucleoside Reverse Transcriptase Inhibitor (HBY-097): A Pharmacokinetic Evaluation in HIV-Positive Patients
|
Hayashi, Sandra
|
|
1999
|
|
10 |
p. 1085-1093
|
artikel
|
| 9 |
American College of Clinical Pharmacology Response to the Institute of Medicine Report “To Err Is Human: Building a Safer Health System”
|
|
|
2000
|
|
10 |
p. 1075-1078
|
artikel
|
| 10 |
An Evaluation of Bioequivalence of Two 7-Day 17β-Estradiol Transdermal Delivery Systems by Anatomical Site
|
Harrison, Lester I.
|
|
2002
|
|
10 |
p. 1134-1141
|
artikel
|
| 11 |
An Evaluation of the Dose-Dependent Inhibition of CYP1A2 by Rofecoxib using Theophylline as a CYP1A2 Probe
|
Bachmann, Kenneth
|
|
2003
|
|
10 |
p. 1082-1090
|
artikel
|
| 12 |
An Evaluation of the Hemostatic Effect of Externally Applied Notoginseng and Notoginseng Total Saponins
|
White, C. Michael
|
|
2000
|
|
10 |
p. 1150-1153
|
artikel
|
| 13 |
An Integrated Glucose-Insulin Model to Describe Oral Glucose Tolerance Test Data in Type 2 Diabetics
|
Jauslin, Petra M.
|
|
2007
|
|
10 |
p. 1244-1255
|
artikel
|
| 14 |
Anticholinergic Activity of Commonly Prescribed Medications and Neuropsychiatric Adverse Events in Older People
|
Nishtala, Prasad S.
|
|
2009
|
|
10 |
p. 1176-1184
|
artikel
|
| 15 |
A Pharmacokinetic Comparison of Generic Tablets Containing Bisoprolol With the Innovator Formulation in Healthy Volunteers
|
Jovanović, Dušan
|
|
2006
|
|
10 |
p. 1217-1222
|
artikel
|
| 16 |
A Pharmacokinetic Study of Intramuscular (IM) Parecoxib Sodium in Normal Subjects
|
Karim, Aziz
|
|
2001
|
|
10 |
p. 1111-1119
|
artikel
|
| 17 |
A Phase I, Single and Fractionated, Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of an Erythropoietin Mimetic Antibody Fusion Protein (CNTO 528) in Healthy Male Subjects
|
Bouman-Thio, Esther
|
|
2008
|
|
10 |
p. 1197-1207
|
artikel
|
| 18 |
Application of Pharmacokinetic Data to Clinical Trials During the IND/NDA Process
|
Harter, John G.
|
|
1976
|
|
10 |
p. 560-564
|
artikel
|
| 19 |
Assessment of the Quality and Quantity of Drug-Drug Interaction Studies in Recent NDA Submissions: Study Design and Data Analysis Issues
|
Huang, Shiew-Mei
|
|
1999
|
|
10 |
p. 1006-1014
|
artikel
|
| 20 |
A Step Toward More Accurate Dosing for Mercaptopurine in Childhood Acute Lymphoblastic Leukemia
|
Mulla, Hussain
|
|
2012
|
|
10 |
p. 1610-1613
|
artikel
|
| 21 |
Author's Response
|
Tutor, J. Carlos
|
|
2008
|
|
10 |
p. 1244-1244
|
artikel
|
| 22 |
Autogenic-Feedback Training Exercise Is Superior to Promethazine for Control of Motion Sickness Symptoms
|
Cowings, Patricia S.
|
|
2000
|
|
10 |
p. 1154-1165
|
artikel
|
| 23 |
Bioavailability and Bloequivalence
|
Skelly, Jerome P.
|
|
1976
|
|
10 |
p. 539-545
|
artikel
|
| 24 |
Bioavailability of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium Is Differentially Affected by Pantoprazole in Healthy Volunteers
|
Rupprecht, Korbinian
|
|
2009
|
|
10 |
p. 1196-1201
|
artikel
|
| 25 |
Bioequivalence of 1 and 5 mg Tacrolimus Capsules Using a Replicate Study Design
|
Bekersky, Ihor
|
|
1999
|
|
10 |
p. 1032-1037
|
artikel
|
| 26 |
Biologic Availability and Therapeutic Equivalence
|
Arnold, John D.
|
|
1976
|
|
10 |
p. 546-549
|
artikel
|
| 27 |
Biomarkers and Coagulation Tests for Assessing the Biosimilarity of a Generic Low-Molecular-Weight Heparin: Results of a Study in Healthy Subjects With Enoxaparin
|
Kuczka, Karina
|
|
2008
|
|
10 |
p. 1189-1196
|
artikel
|
| 28 |
Book Review: Biology of the Major Psychoses: A Comparative Analysis (Association for Research in Nervous and Mental Disease, Vol. 54)
|
Procita, Leonard
|
|
1976
|
|
10 |
p. 530-531
|
artikel
|
| 29 |
Book Review: Cardiac Physiology for the Clinician
|
Procita, Leonard
|
|
1976
|
|
10 |
p. 529-530
|
artikel
|
| 30 |
Book Review: Central Cholinergic Systems and Behaviour
|
Procita, Leonard
|
|
1976
|
|
10 |
p. 531-532
|
artikel
|
| 31 |
Book Review: Disorders of Voluntary Muscle
|
Procita, Leonard
|
|
1976
|
|
10 |
p. 532-534
|
artikel
|
| 32 |
Book Review: Drug Action and Drug Resistance in Bacteria. 2. Aminoglycoside Antibiotics
|
Procita, Leonard
|
|
1976
|
|
10 |
p. 527-527
|
artikel
|
| 33 |
Book Review: Drug Treatment of Mental Disorders
|
Procita, Leonard
|
|
1976
|
|
10 |
p. 528-528
|
artikel
|
| 34 |
Book Review: Opiate Receptor Mechanisms
|
Procita, Leonard
|
|
1976
|
|
10 |
p. 528-529
|
artikel
|
| 35 |
Book Review: Pharmacognosy, 10th edition
|
Procita, Leonard
|
|
1976
|
|
10 |
p. 526-527
|
artikel
|
| 36 |
Book Review: Pharmacologic Testing in a Correctional Institution
|
Procita, Leonard
|
|
1976
|
|
10 |
p. 525-526
|
artikel
|
| 37 |
Book Review: The Metabolism of Contraction. (Recent Advances in Studies on Cardiac Structure and Metabolism, Vol. 10)
|
Procita, Leonard
|
|
1976
|
|
10 |
p. 527-528
|
artikel
|
| 38 |
Books Received
|
|
|
1976
|
|
10 |
p. 534-534
|
artikel
|
| 39 |
Cardiac Adverse Effects of Early Dexamethasone Treatment in Preterm Infants: A Randomized Clinical Trial
|
Zecca, Enrico
|
|
2001
|
|
10 |
p. 1075-1081
|
artikel
|
| 40 |
Carnitine-Induced Effects on Cardiac and Peripheral Hemodynamics
|
Brooks, Harold
|
|
1977
|
|
10 |
p. 561-568
|
artikel
|
| 41 |
Characterization of Total Plasma Glycosaminoglycan Levels in Healthy Volunteers Following Oral Administration of a Novel Antithrombotic Odiparcil With Aspirin or Enoxaparin
|
Myers, Alan L.
|
|
2008
|
|
10 |
p. 1158-1170
|
artikel
|
| 42 |
Ciprofloxacin Prolonged-Release Tablets Do Not Affect Warfarin Pharmacokinetics and Pharmacodynamics
|
Washington, Carla
|
|
2007
|
|
10 |
p. 1320-1326
|
artikel
|
| 43 |
Circadian Intraocular Pressure and Blood Pressure Reduction With Timolol 0.5% Solution and Timogel 0.1% in Patients With Primary Open-Angle Glaucoma
|
Quaranta, Luciano
|
|
2012
|
|
10 |
p. 1552-1557
|
artikel
|
| 44 |
Clarification on Precision Criteria to Derive Sample Size When Designing Pediatric Pharmacokinetic Studies
|
Wang, Yaning
|
|
2012
|
|
10 |
p. 1601-1606
|
artikel
|
| 45 |
Clinical Research-Some Legal Problems of the Pharmaceutical Manufacturer
|
Johnson, Daniel R.
|
|
1976
|
|
10 |
p. 600-604
|
artikel
|
| 46 |
Clinical Trial Design Issues: At Least 10 Things You Should Look For in Clinical Trials
|
Glasser, Stephen P.
|
|
2006
|
|
10 |
p. 1106-1115
|
artikel
|
| 47 |
Clopidogrel Pharmacodynamics and Pharmacokinetics in the Fed and Fasted State: A Randomized Crossover Study of Healthy Men
|
Hurbin, Fabrice
|
|
2012
|
|
10 |
p. 1506-1515
|
artikel
|
| 48 |
Coadministration of Dalcetrapib With Pravastatin, Rosuvastatin, or Simvastatin: No Clinically Relevant Drug-Drug Interactions
|
Derks, Michael
|
|
2010
|
|
10 |
p. 1188-1201
|
artikel
|
| 49 |
Coadministration of Lansoprazole and Naproxen Does Not Affect the Pharmacokinetic Profile of Methotrexate in Adult Patients With Rheumatoid Arthritis
|
Vakily, Majid
|
|
2005
|
|
10 |
p. 1179-1186
|
artikel
|
| 50 |
Coadministration of Pioglitazone or Glyburide and Alogliptin: Pharmacokinetic Drug Interaction Assessment in Healthy Participants
|
Karim, Aziz
|
|
2009
|
|
10 |
p. 1210-1219
|
artikel
|
| 51 |
Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX-2 versus COX-1 in Healthy Volunteers
|
Van Hecken, Anne
|
|
2000
|
|
10 |
p. 1109-1120
|
artikel
|
| 52 |
Comparison of N-Acetyltransferase-2 Enzyme Genotype-Phenotype and Xanthine Oxidase Enzyme Activity Between Swedes and Koreans
|
Djordjevic, Natasa
|
|
2012
|
|
10 |
p. 1527-1534
|
artikel
|
| 53 |
Considerations for Clinical Trial Design and Data Analyses of Thorough QT Studies Using Drug-Drug Interaction
|
Hao Zhu,
|
|
2010
|
|
10 |
p. 1106-1111
|
artikel
|
| 54 |
Considerations in the Use of Drugs in Patients with Renal Failure
|
Le Sher, Dean A.
|
|
1976
|
|
10 |
p. 570-576
|
artikel
|
| 55 |
Could the WHO Model List of Essential Medicines Do More for the Safe and Appropriate Use of Injections?
|
Logez, Sophie M. D.
|
|
2004
|
|
10 |
p. 1106-1113
|
artikel
|
| 56 |
Criminal Culpability of Physicians in the Dispensing and Distribution of Controlled Dangerous Substances
|
Winter, Robert T.
|
|
1976
|
|
10 |
p. 584-588
|
artikel
|
| 57 |
CYP3A5 but Not CYP2D6 Polymorphism Contributes Significantly to the Variability in Dextropropoxyphene Disposition
|
Yin, Ophelia Q. P.
|
|
2010
|
|
10 |
p. 1136-1141
|
artikel
|
| 58 |
Cytokines and Toxicity in Acetaminophen Overdose
|
James, Laura P.
|
|
2005
|
|
10 |
p. 1165-1171
|
artikel
|
| 59 |
Dermal Absorption of Camphor, Menthol, and Methyl Salicylate in Humans
|
Martin, Debra
|
|
2004
|
|
10 |
p. 1151-1157
|
artikel
|
| 60 |
Differences in Drug Pharmacokinetics between East Asians and Caucasians and the Role of Genetic Polymorphisms
|
Kim, Kiman
|
|
2004
|
|
10 |
p. 1083-1105
|
artikel
|
| 61 |
Disposition and Metabolite Kinetics of Oral L-carnitine in Humans
|
Bain, Marcus A.
|
|
2006
|
|
10 |
p. 1163-1170
|
artikel
|
| 62 |
Disposition of Recombinant Human Interleukin-10 in Subjects with Various Degrees of Renal Function
|
Andersen, Scott R.
|
|
1999
|
|
10 |
p. 1015-1020
|
artikel
|
| 63 |
Disregard by Practitioners of the High Abuse Potential of Controlled Dangerous Substances
|
LaBue, Anthony F.
|
|
1976
|
|
10 |
p. 581-583
|
artikel
|
| 64 |
Dose-Proportional and Stereospecific Pharmacokinetics of Methylphenidate Delivered Using an Osmotic, Controlled-Release Oral Delivery System
|
Modi, Nishit B.
|
|
2000
|
|
10 |
p. 1141-1149
|
artikel
|
| 65 |
Dose Proportionality of Oral Etoricoxib, a Highly Selective Cyclooxygenase-2 Inhibitor, in Healthy Volunteers
|
Agrawal, Nancy G. B.
|
|
2001
|
|
10 |
p. 1106-1110
|
artikel
|
| 66 |
Dose-Related Reduction in Bupropion Plasma Concentrations by Ritonavir
|
Park, Joohyun
|
|
2010
|
|
10 |
p. 1180-1187
|
artikel
|
| 67 |
Doxycycline-Induced Hypoglycemia
|
Odeh, Majed
|
|
2000
|
|
10 |
p. 1173-1174
|
artikel
|
| 68 |
Drug-binding Cavities in Long-Lived Biologics: Cause for Concern but Also Potential Benefit
|
Panayotatos, Nikos
|
|
2008
|
|
10 |
p. 1208-1211
|
artikel
|
| 69 |
Drug Burden Index, Physical Function, and Adverse Outcomes in Older Hospitalized Patients
|
Lowry, Estelle
|
|
2012
|
|
10 |
p. 1584-1591
|
artikel
|
| 70 |
Drugs Released for Clinical Use
|
De Haen, Paul
|
|
1976
|
|
10 |
p. 535-536
|
artikel
|
| 71 |
Effect of a High-Fat Meal on the Pharmacokinetics of Saxagliptin in Healthy Subjects
|
Patel, Chirag G.
|
|
2010
|
|
10 |
p. 1211-1216
|
artikel
|
| 72 |
Effect of Cinacalcet Hydrochloride, a New Calcimimetic Agent, on the Pharmacokinetics of Dextromethorphan: In Vitro and Clinical Studies
|
Nakashima, Daisuke
|
|
2007
|
|
10 |
p. 1311-1319
|
artikel
|
| 73 |
Effect of Doxazosin on Arterial Elasticity: Functional versus Structural Changes
|
Bratteli, Chris W.
|
|
2002
|
|
10 |
p. 1105-1108
|
artikel
|
| 74 |
Effect of Exenatide on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Asian Men
|
Soon, Danny
|
|
2006
|
|
10 |
p. 1179-1187
|
artikel
|
| 75 |
Effect of Food on the Bioavailability of Amlodipine Besylate/Atorvastatin Calcium Combination Tablet
|
Chung, Menger
|
|
2006
|
|
10 |
p. 1212-1216
|
artikel
|
| 76 |
Effect of Mibefradil on CYP3A4 in Vivo
|
Veronese, Maria L.
|
|
2003
|
|
10 |
p. 1091-1100
|
artikel
|
| 77 |
Effect of Phosphate Binders on Supplemental Iron Absorption in Healthy Subjects
|
Pruchnicki, Maria C.
|
|
2002
|
|
10 |
p. 1171-1176
|
artikel
|
| 78 |
Effect of Seville Orange Juice and Grapefruit Juice on Indinavir Pharmacokinetics
|
Penzak, Scott R.
|
|
2002
|
|
10 |
p. 1165-1170
|
artikel
|
| 79 |
Effect of Telaprevir on the Pharmacokinetics of Midazolam and Digoxin
|
Garg, Varun
|
|
2012
|
|
10 |
p. 1566-1573
|
artikel
|
| 80 |
Effects of Concomitant Therapy with Diltiazem on the Lipid Responses to Simvastatin in Chinese Subjects
|
You, Joyce H. S.
|
|
2010
|
|
10 |
p. 1151-1158
|
artikel
|
| 81 |
Effects of Hypericum perforatum on Ivabradine Pharmacokinetics in Healthy Volunteers: An Open-Label, Pharmacokinetic Interaction Clinical Trial
|
Portoles, A.
|
|
2006
|
|
10 |
p. 1188-1194
|
artikel
|
| 82 |
Effects of Low-Dose Pravastatin on Plasma Levels of Lipids and Apolipoproteins in Japanese Type II Hyperlipoproteinemic Subjects with Apolipoprotein E Phenotype E3/2, E3/3, and E4/3
|
Kobayashi, Toshio
|
|
2001
|
|
10 |
p. 1055-1058
|
artikel
|
| 83 |
Efficacy and Safety of Ketoprofen Patch in Patients With Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Study
|
Kawai, Shinichi
|
|
2010
|
|
10 |
p. 1171-1179
|
artikel
|
| 84 |
Enzyme Replacement in Fabry Disease: Pharmacokinetics and Pharmacodynamics of Agalsidase Alfa in Children and Adolescents
|
Ries, Markus
|
|
2007
|
|
10 |
p. 1222-1230
|
artikel
|
| 85 |
Errata
|
|
|
2006
|
|
10 |
p. 1225-1226
|
artikel
|
| 86 |
Erratum
|
|
|
2005
|
|
10 |
p. 1206-1206
|
artikel
|
| 87 |
Estimation of Creatinine Clearance
|
Jelliffe, Roger
|
|
2008
|
|
10 |
p. 1242-1244
|
artikel
|
| 88 |
Estimation of Human Drug Clearance Using Multiexponential Techniques
|
Goteti, Kosalaram
|
|
2008
|
|
10 |
p. 1226-1236
|
artikel
|
| 89 |
Examination of the Effect of Increasing Doses of Etoricoxib on Oral Methotrexate Pharmacokinetics in Patients With Rheumatoid Arthritis
|
Schwartz, Jules I.
|
|
2009
|
|
10 |
p. 1202-1209
|
artikel
|
| 90 |
Factors Involved in the Pharmacokinetics of COL-3, a Matrix Metalloproteinase Inhibitor, in Patients with Refractory Metastatic Cancer: Clinical and Experimental Studies
|
Rudek, Michelle A.
|
|
2003
|
|
10 |
p. 1124-1135
|
artikel
|
| 91 |
Flunitrazepam, an Investigational Hypnotic Drug Sleep Laboratory Evaluations
|
Bixler, Edward O.
|
|
1977
|
|
10 |
p. 569-578
|
artikel
|
| 92 |
Fluoxetine Bioequivalence Study: Quantification of Fluoxetine and Norfluoxetine by Liquid Chromatography Coupled to Mass Spectrometry
|
Moraes, M. O.
|
|
1999
|
|
10 |
p. 1053-1061
|
artikel
|
| 93 |
Food Effect on Bioavailability of Modified-Release Trimetazidine Tablets
|
Ozbay, Latif
|
|
2012
|
|
10 |
p. 1535-1539
|
artikel
|
| 94 |
Gatifloxacin Pharmacokinetics in Healthy Men and Women
|
Zhang, Xin
|
|
2006
|
|
10 |
p. 1154-1162
|
artikel
|
| 95 |
Hand-Foot Syndrome in Patients Treated with Capecitabine-Containing Combination Chemotherapy
|
Heo, Young Seol
|
|
2004
|
|
10 |
p. 1166-1172
|
artikel
|
| 96 |
Hemodynamic Interaction Between a Daily Dosed Phosphodiesterase 5 Inhibitor, Tadalafil, and the α-Adrenergic Blockers, Doxazosin and Tamsulosin, in Middle-Aged Healthy Male Subjects
|
Guillaume, Michel
|
|
2007
|
|
10 |
p. 1303-1310
|
artikel
|
| 97 |
How First-Time-in-Human Studies Are Being Performed: A Survey of Phase I Dose-Escalation Trials in Healthy Volunteers Published Between 1995 and 2004
|
Buoen, Camilla
|
|
2005
|
|
10 |
p. 1123-1136
|
artikel
|
| 98 |
Human Safety and Pharmacokinetic Study of Intramuscular Midazolam Administered by Autoinjector
|
Reichard, Douglas W.
|
|
2010
|
|
10 |
p. 1128-1135
|
artikel
|
| 99 |
Increased Bioavailability of 11-Keto-β-Boswellic Acid Following Single Oral Dose Frankincense Extract Administration After a Standardized Meal in Healthy Male Volunteers: Modeling and Simulation Considerations for Evaluating Drug Exposures
|
Skarke, Carsten
|
|
2012
|
|
10 |
p. 1592-1600
|
artikel
|
| 100 |
Industry's Role in Bloavailability
|
Weiner, Murray
|
|
1976
|
|
10 |
p. 550-553
|
artikel
|
| 101 |
Influence of Food Intake on the Pharmacokinetics of Miglustat, an Inhibitor of Glucosylceramide Synthase
|
van Giersbergen, Paul L. M.
|
|
2007
|
|
10 |
p. 1277-1282
|
artikel
|
| 102 |
Interaction Trial between Artemether-Lumefantrine (Riamet®) and Quinine in Healthy Subjects
|
Lefèvre, Gilbert
|
|
2002
|
|
10 |
p. 1147-1158
|
artikel
|
| 103 |
Interpretation of Bioavailability Data by Practitioners
|
Schumacher, G. E.
|
|
1976
|
|
10 |
p. 554-559
|
artikel
|
| 104 |
Intramuscular Haloperidol or Lorazepam and QT Intervals in Schizophrenia
|
Harvey, Anne T.
|
|
2004
|
|
10 |
p. 1173-1184
|
artikel
|
| 105 |
Investigation of a Potential Food Effect on the Pharmacokinetics of Roflumilast, an Oral, Once-Daily Phosphodiesterase 4 Inhibitor, in Healthy Subjects
|
Hauns, Bernhard
|
|
2006
|
|
10 |
p. 1146-1153
|
artikel
|
| 106 |
In Vitro and Clinical Investigation of the Relationship Between CCR5 Receptor Occupancy and Anti-HIV Activity of Aplaviroc
|
Demarest, James F.
|
|
2008
|
|
10 |
p. 1179-1188
|
artikel
|
| 107 |
Lack of Correlation between the Steady-State Plasma Concentrations of Haloperidol and Risperidone
|
Yasui-Furukori, Norio
|
|
2002
|
|
10 |
p. 1083-1088
|
artikel
|
| 108 |
Lack of Effect of Antacids on Single-Dose Pharmacokinetics of Etoricoxib
|
Schwartz, Jules I.
|
|
2007
|
|
10 |
p. 1342-1346
|
artikel
|
| 109 |
Lack of Erectogenic Activity of a Novel Selective Melanocortin-4 Receptor Agonist in a Clinical Experimental Model
|
Krishna, Rajesh
|
|
2008
|
|
10 |
p. 1237-1241
|
artikel
|
| 110 |
Lack of Pharmacokinetic Interaction Between Omeprazole or Lansoprazole and Ivabradine in Healthy Volunteers: An Open-Label, Randomized, Crossover, Pharmacokinetic Interaction Clinical Trial
|
Portolés, A.
|
|
2006
|
|
10 |
p. 1195-1203
|
artikel
|
| 111 |
Lack of Pharmacokinetic Interaction between Rofecoxib and Methotrexate in Rheumatoid Arthritis Patients
|
Schwartz, Jules I.
|
|
2001
|
|
10 |
p. 1120-1130
|
artikel
|
| 112 |
Legal Aspects of Experimentation with Institutionalized Mentally Disabled Subjects
|
Laves, Benjamin S.
|
|
1976
|
|
10 |
p. 592-599
|
artikel
|
| 113 |
Legal Implications in the Alternatives to the Use of Experimental Animals
|
Meth, Theodore
|
|
1976
|
|
10 |
p. 589-591
|
artikel
|
| 114 |
Levosimendan: Implications for Clinicians
|
McBride, Brian F.
|
|
2003
|
|
10 |
p. 1071-1081
|
artikel
|
| 115 |
Lumiracoxib Does Not Affect the Ex Vivo Antiplatelet Aggregation Activity of Low-Dose Aspirin in Healthy Subjects
|
Jermany, J.
|
|
2005
|
|
10 |
p. 1172-1178
|
artikel
|
| 116 |
Lung Deposition of Radiolabeled Tiotropium in Healthy Subjects and Patients With Chronic Obstructive Pulmonary Disease
|
Brand, Peter
|
|
2007
|
|
10 |
p. 1335-1341
|
artikel
|
| 117 |
MDR1 Haplotypes do not Affect the Steady-State Pharmacokinetics of Cyclosporine in Renal Transplant Patients
|
Mai, Ingrid
|
|
2003
|
|
10 |
p. 1101-1107
|
artikel
|
| 118 |
Multiple-Dose Pharmacokinetics and Safety of Desloratadine in Subjects With Moderate Hepatic Impairment
|
Gupta, Samir K.
|
|
2007
|
|
10 |
p. 1283-1291
|
artikel
|
| 119 |
Multiple-Dose Safety, Pharmacokinetics, and Pharmacodynamics of the µ-Opioid Receptor Inverse Agonist GSK1521498
|
Nathan, Pradeep J.
|
|
2012
|
|
10 |
p. 1456-1467
|
artikel
|
| 120 |
Multiple Doses of Sitagliptin, a Selective DPP-4 Inhibitor, Do Not Meaningfully Alter Pharmacokinetics and Pharmacodynamics of Warfarin
|
Wright, D. Hamish
|
|
2009
|
|
10 |
p. 1157-1167
|
artikel
|
| 121 |
Near-Thorough QT Study as Part of a First-In-Man Study
|
Malik, Marek
|
|
2008
|
|
10 |
p. 1146-1157
|
artikel
|
| 122 |
No Effect of Age or Gender on the Pharmacokinetics of Rosuvastatin: A New HMG-CoA Reductase Inhibitor
|
Martin, Paul D.
|
|
2002
|
|
10 |
p. 1116-1121
|
artikel
|
| 123 |
No Effect of Gender or Age on Binding Characteristics of Valproic Acid to Serum Proteins in Pediatric Patients with Epilepsy
|
Kodama, Yasuo
|
|
1999
|
|
10 |
p. 1070-1076
|
artikel
|
| 124 |
Operating Characteristics of a Partial-Block Randomized Crossover Bioequivalence Study for Dutasteride, a Drug With a Long Half-Life: Investigation Through Simulation and Comparison With Final Results
|
Gengqian Cai,
|
|
2010
|
|
10 |
p. 1142-1150
|
artikel
|
| 125 |
Opioids, QTc Prolongation, and Torsades
|
Kurt, Thomas L.
|
|
2012
|
|
10 |
p. 1614-1614
|
artikel
|
| 126 |
Optimal Adaptive Design in Clinical Drug Development: A Simulation Example
|
Maloney, Alan
|
|
2007
|
|
10 |
p. 1231-1243
|
artikel
|
| 127 |
P-glycoprotein and Drug Therapy in Organ Transplantation
|
Lo, Agnes
|
|
1999
|
|
10 |
p. 995-1005
|
artikel
|
| 128 |
Pharmacodynamics and Pharmacokinetics of Oral Levosimendan and Its Metabolites in Patients with Severe Congestive Heart Failure: A Dosing Interval Study
|
Põder, Pentti
|
|
2004
|
|
10 |
p. 1143-1150
|
artikel
|
| 129 |
Pharmacodynamics, Pharmacokinetics, and Safety of AM211: A Novel and Potent Antagonist of the Prostaglandin D2 Receptor Type 2
|
Bain, G.
|
|
2012
|
|
10 |
p. 1482-1493
|
artikel
|
| 130 |
Pharmacokinetic Evaluation and Safety Profile of a 15-Minute Versus 30-Second Infusion of Palonosetron in Healthy Subjects
|
Shah, Ajit
|
|
2006
|
|
10 |
p. 1139-1145
|
artikel
|
| 131 |
Pharmacokinetic Interactions between Sirolimus and Microemulsion Cyclosporine when Orally Administered Jointly and 4 Hours Apart in Healthy Volunteers
|
Zimmerman, James J.
|
|
2003
|
|
10 |
p. 1168-1176
|
artikel
|
| 132 |
Pharmacokinetic-Pharmacodynamic Modeling of Rivastigmine, a Cholinesterase Inhibitor, in Patients with Alzheimer's Disease
|
Gobburu, J. V.S.
|
|
2001
|
|
10 |
p. 1082-1090
|
artikel
|
| 133 |
Pharmacokinetics and Absolute Bioavailability of Selegiline Following Treatment of Healthy Subjects With the Selegiline Transdermal System (6 mg/24 h): A Comparison With Oral Selegiline Capsules
|
Azzaro, Albert J.
|
|
2007
|
|
10 |
p. 1256-1267
|
artikel
|
| 134 |
Pharmacokinetics and Concentration-Effect Analysis of Intravenous RGD891, a Platelet GPIIb/IIIa Antagonist, Using Mixed-Effects Modeling (NONMEM)
|
Zannikos, Peter N.
|
|
2000
|
|
10 |
p. 1129-1140
|
artikel
|
| 135 |
Pharmacokinetics and Pharmacodynamics of Drospirenone-Estradiol Combination Hormone Therapy Product Coadministered With Hydrochlorothiazide in Hypertensive Postmenopausal Women
|
Karara, Adel H.
|
|
2007
|
|
10 |
p. 1292-1302
|
artikel
|
| 136 |
Pharmacokinetics and Pharmacodynamics of Thalidomide in HIV Patients Treated for Oral Aphthous Ulcers: ACTG Protocol 251
|
Aweeka, Francesca
|
|
2001
|
|
10 |
p. 1091-1097
|
artikel
|
| 137 |
Pharmacokinetics and Pharmacodynamics of the Urotensin-II Receptor Antagonist Palosuran in Healthy Male Subjects
|
Sidharta, Patricia N.
|
|
2009
|
|
10 |
p. 1168-1175
|
artikel
|
| 138 |
Pharmacokinetics and Tolerability of GW420867X, a Nonnucleoside Reverse Transcriptase Inhibitor, following Single Escalating Doses in Healthy Male Volunteers
|
Moore, Katy H. P.
|
|
2001
|
|
10 |
p. 1098-1105
|
artikel
|
| 139 |
Pharmacokinetics of a Novel Diltiazem HCl Extended-Release Tablet Formulation for Evening Administration
|
Sista, Suryanarayana
|
|
2003
|
|
10 |
p. 1149-1157
|
artikel
|
| 140 |
Pharmacokinetics of Anthocyanins and Ellagic Acid in Healthy Volunteers Fed Freeze-Dried Black Raspberries Daily for 7 Days
|
Stoner, Gary D.
|
|
2005
|
|
10 |
p. 1153-1164
|
artikel
|
| 141 |
Pharmacokinetics of Desmopressin Administrated as an Oral Lyophilisate Dosage Form in Children With Primary Nocturnal Enuresis and Healthy Adults
|
Østerberg, Ole
|
|
2006
|
|
10 |
p. 1204-1211
|
artikel
|
| 142 |
Pharmacokinetics of Dextromethorphan after Single or Multiple Dosing in Combination with Quinidine in Extensive and Poor Metabolizers
|
Pope, Laura E.
|
|
2004
|
|
10 |
p. 1132-1142
|
artikel
|
| 143 |
Pharmacokinetics of Ertapenem in Patients With VaryingDegrees of Renal Insufficiency and in Patients on Hemodialysis
|
Mistry, Goutam C.
|
|
2006
|
|
10 |
p. 1128-1138
|
artikel
|
| 144 |
Pharmacokinetics of Erythromycin on Repetitive Dosing
|
Colburn, Wayne A.
|
|
1977
|
|
10 |
p. 592-600
|
artikel
|
| 145 |
Pharmacokinetics of Etoricoxib in Patients with Hepatic Impairment
|
Agrawal, Nancy G. B.
|
|
2003
|
|
10 |
p. 1136-1148
|
artikel
|
| 146 |
Pharmacokinetics of Frovatriptan in Adolescent Migraineurs
|
Elkind, Arthur H.
|
|
2004
|
|
10 |
p. 1158-1165
|
artikel
|
| 147 |
Pharmacokinetics of Micafungin in Healthy Volunteers, Volunteers With Moderate Liver Disease, and Volunteers With Renal Dysfunction
|
Hebert, Mary F.
|
|
2005
|
|
10 |
p. 1145-1152
|
artikel
|
| 148 |
Pharmacokinetics of Tipifarnib After Oral and Intravenous Administration in Subjects With Advanced Cancer
|
Zhang, Steven
|
|
2006
|
|
10 |
p. 1116-1127
|
artikel
|
| 149 |
Pharmacokinetics, Safety, and Tolerability of Phentermine in Healthy Participants Receiving Taranabant, a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist
|
Addy, Carol
|
|
2009
|
|
10 |
p. 1228-1238
|
artikel
|
| 150 |
Pharmacokinetics, Safety, and Tolerability of Single Intravenous Infusions of an Adenosine Agonist, AMP 579, in Healthy Male Volunteers
|
Zannikos, Peter N.
|
|
1999
|
|
10 |
p. 1044-1052
|
artikel
|
| 151 |
Plasma and Cerebrospinal Fluid Pharmacokinetics of Naproxen in Children
|
Välitalo, Pyry
|
|
2012
|
|
10 |
p. 1516-1526
|
artikel
|
| 152 |
Population Pharmacokinetic Analysis and Dosing Regimen Optimization of Meropenem in Adult Patients
|
Li, Chonghua
|
|
2006
|
|
10 |
p. 1171-1178
|
artikel
|
| 153 |
Population Pharmacokinetic Analysis of Panitumumab in Patients With Advanced Solid Tumors
|
Ma, Peiming
|
|
2009
|
|
10 |
p. 1142-1156
|
artikel
|
| 154 |
Population Pharmacokinetic-Pharmacodynamic Analysis of Istradefylline in Patients With Parkinson Disease
|
Knebel, William
|
|
2012
|
|
10 |
p. 1468-1481
|
artikel
|
| 155 |
Population Pharmacokinetics and Pharmacodynamics of Inhaled Ciclesonide and Fluticasone Propionate in Patients With Persistent Asthma
|
Jian Xu,
|
|
2010
|
|
10 |
p. 1118-1127
|
artikel
|
| 156 |
Population Pharmacokinetics of Ibuprofen Enantiomers in Very Premature Neonates
|
Gregoire, Nicolas
|
|
2004
|
|
10 |
p. 1114-1124
|
artikel
|
| 157 |
Psychopharmacology and the Law: A Forensic Psychiatrist's Viewpoint
|
Feldman, Harold S.
|
|
1976
|
|
10 |
p. 577-580
|
artikel
|
| 158 |
Quantitative Model of the Relationship Between Dipeptidyl Peptidase-4 (DPP-4) Inhibition and Response: Meta-Analysis of Alogliptin, Saxagliptin, Sitagliptin, and Vildagliptin Efficacy Results
|
Gibbs, John P.
|
|
2012
|
|
10 |
p. 1494-1505
|
artikel
|
| 159 |
Quantitative Structure-Property Relationships Modeling to Predict In Vitro and In Vivo Binding of Drugs to the Bile Sequestrant, Colesevelam (Welchol)
|
Walker, Joseph R.
|
|
2009
|
|
10 |
p. 1185-1195
|
artikel
|
| 160 |
Relative Contribution of CYP3A to Amitriptyline Clearance in Humans: in Vitro and in Vivo Studies
|
Venkatakrishnan, Karthik
|
|
2001
|
|
10 |
p. 1043-1054
|
artikel
|
| 161 |
Renal Transplantation in a Case of Acute Intermittent Porphyria
|
Warholm, Carl
|
|
2003
|
|
10 |
p. 1158-1160
|
artikel
|
| 162 |
Review: Opioid Modulation of Oxytocin Release
|
Morris, Mark S.
|
|
2010
|
|
10 |
p. 1112-1117
|
artikel
|
| 163 |
Romiplostim Dose Response in Patients With Immune Thrombocytopenia
|
Perez-Ruixo, J. J.
|
|
2012
|
|
10 |
p. 1540-1551
|
artikel
|
| 164 |
Safety and Pharmacokinetics of Multiple Doses of Aclidinium Bromide, a Novel Long-Acting Muscarinic Antagonist for the Treatment of Chronic Obstructive Pulmonary Disease, in Healthy Participants
|
Jansat, Josep M.
|
|
2009
|
|
10 |
p. 1239-1246
|
artikel
|
| 165 |
Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects
|
Guzzo, Cynthia A.
|
|
2002
|
|
10 |
p. 1122-1133
|
artikel
|
| 166 |
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of BI 1356, an Inhibitor of Dipeptidyl Peptidase 4, in Healthy Male Volunteers
|
Hüttner, S.
|
|
2008
|
|
10 |
p. 1171-1178
|
artikel
|
| 167 |
Sensitivity of Intravenous and Oral Alfentanil and Pupillary Miosis as Minimally Invasive and Noninvasive Probes for Hepatic and First-Pass CYP3A Activity
|
Kharasch, Evan D.
|
|
2005
|
|
10 |
p. 1187-1197
|
artikel
|
| 168 |
Seville (sour) Orange Juice: Synephrine Content and Cardiovascular Effects in Normotensive Adults
|
Penzak, Scott R.
|
|
2001
|
|
10 |
p. 1059-1063
|
artikel
|
| 169 |
Shortening of the QT Interval After Food Can Be Used to Demonstrate Assay Sensitivity in Thorough QT Studies
|
Taubel, Jorg
|
|
2012
|
|
10 |
p. 1558-1565
|
artikel
|
| 170 |
Single- and Multiple-Dose Pharmacokinetics of Pioglitazone in Adolescents With Type 2 Diabetes
|
Christensen, Michael L.
|
|
2005
|
|
10 |
p. 1137-1144
|
artikel
|
| 171 |
Single- and Multiple-Dose Pharmacokinetics of Pirfenidone, an Antifibrotic Agent, in Healthy Chinese Volunteers
|
Shaojun Shi,
|
|
2007
|
|
10 |
p. 1268-1276
|
artikel
|
| 172 |
Single-Dose Pharmacokinetics and Safety of Pegylated Interferon-α2b in Patients with Chronic Renal Dysfunction
|
Gupta, Samir K.
|
|
2002
|
|
10 |
p. 1109-1115
|
artikel
|
| 173 |
Single-Dose Pharmacokinetics of Nizatidine (Axid®) in Children
|
Abdel-Rahman, Susan M.
|
|
2002
|
|
10 |
p. 1089-1096
|
artikel
|
| 174 |
Single Plasma Concentrations of 1'-Hydroxymidazolam or the Ratio of 1'-Hydroxymidazolam:Midazolam Do Not Predict Midazolam Clearance in Healthy Subjects
|
Rogers, Janyce F.
|
|
2002
|
|
10 |
p. 1079-1082
|
artikel
|
| 175 |
Structure Elucidation and Biological Activity of the Oversulfated Chondroitin Sulfate Contaminant in Baxter Heparin
|
McKee, Jeff
|
|
2010
|
|
10 |
p. 1159-1170
|
artikel
|
| 176 |
Studies on Absorption of a Newly Developed Enteric-Coated Erythromycin Base
|
McDonald, P. J.
|
|
1977
|
|
10 |
p. 601-606
|
artikel
|
| 177 |
Suspected Clonazepam-Induced Bullous Dermatosis in a Patient With Respiratory Failure
|
Lee, Ming-Chia
|
|
2012
|
|
10 |
p. 1607-1609
|
artikel
|
| 178 |
20th-Century Advances in Drug Therapy in Oncology—Part II
|
Dutcher, Janice P.
|
|
2000
|
|
10 |
p. 1079-1092
|
artikel
|
| 179 |
The Antiparasitic Moxidectin: Safety, Tolerability, and Pharmacokinetics in Humans
|
Cotreau, Monette M.
|
|
2003
|
|
10 |
p. 1108-1115
|
artikel
|
| 180 |
The Application of Accelerator Mass Spectrometry to Absolute Bioavailability Studies in Humans: Simultaneous Administration of an Intravenous Microdose of 14C-Nelfinavir Mesylate Solution and Oral Nelfinavir to Healthy Volunteers
|
Sarapa, Nenad
|
|
2005
|
|
10 |
p. 1198-1205
|
artikel
|
| 181 |
The Effect of Erythromycin and Clarithromycin on the Pharmacokinetics of Intravenous Digoxin in Healthy Volunteers
|
Tsutsumi, Kimiko
|
|
2002
|
|
10 |
p. 1159-1164
|
artikel
|
| 182 |
The Effect of Pharmacokinetically Guided Acute Intravenous Testosterone Administration on Electrocardiographic and Blood Pressure Variables
|
White, C. Michael
|
|
1999
|
|
10 |
p. 1038-1043
|
artikel
|
| 183 |
The Effect of Raltegravir on the Glucuronidation of Lamotrigine
|
van Luin, Matthijs
|
|
2009
|
|
10 |
p. 1220-1227
|
artikel
|
| 184 |
The Effects of Modifying in Vivo Cytochrome P450 3A (CYP3A) Activity on Etoricoxib Pharmacokinetics and of Etoricoxib Administration on CYP3A Activity
|
Agrawal, Nancy G. B.
|
|
2004
|
|
10 |
p. 1125-1131
|
artikel
|
| 185 |
The Effects of Tegaserod (HTF 919) on the Pharmacokinetics and Pharmacodynamics of Digoxin in Healthy Subjects
|
Zhou, Honghui
|
|
2001
|
|
10 |
p. 1131-1139
|
artikel
|
| 186 |
The Importance of the Pharmacist in Reporting Adverse Drug Reactions in the Emergency Department
|
Ratz, Yael
|
|
2010
|
|
10 |
p. 1217-1221
|
artikel
|
| 187 |
The Law and Clinical Pharmacy
|
Fink, Joseph L.
|
|
1976
|
|
10 |
p. 605-608
|
artikel
|
| 188 |
The New Topical Steroid Ciclesonide Is Effective in the Treatment of Allergic Rhinitis
|
Schmidt, Bernhard M. W.
|
|
1999
|
|
10 |
p. 1062-1069
|
artikel
|
| 189 |
The Pharmacokinetic Interaction Between an Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone and the HCV Protease Inhibitor Telaprevir
|
Garg, Varun
|
|
2012
|
|
10 |
p. 1574-1583
|
artikel
|
| 190 |
The Pharmacokinetics of Enalapril in Children and Infants with Hypertension
|
Wells, Thomas
|
|
2001
|
|
10 |
p. 1064-1074
|
artikel
|
| 191 |
The Pharmacokinetics of Extended-Release Formulations of Calcium Antagonists and of Amlodipine in Subjects with Different Gastrointestinal Transit Times
|
Zimmermann, Torsten
|
|
1999
|
|
10 |
p. 1-11
|
artikel
|
| 192 |
The Pharmacokinetics of Linezolid are not Affected by Concomitant Intake of the Antioxidant Vitamins C and E
|
Gordi, Toufigh
|
|
2003
|
|
10 |
p. 1161-1167
|
artikel
|
| 193 |
The Private Practice Research Group (PPRG): A Working Model from Psychopharmacology for Clinical Research in Family Practice
|
Rickels, Karl
|
|
1977
|
|
10 |
p. 541-554
|
artikel
|
| 194 |
TherapeuticReview: Pharmacologic Consideration for the Use of Antiretroviral Agents in the Elderly
|
Rhee, Martin S.
|
|
2008
|
|
10 |
p. 1212-1225
|
artikel
|
| 195 |
The Relationship between Terazosin Dose and Blood Pressure Response in Hypertensive Patients
|
Achari, Ramanuj
|
|
2000
|
|
10 |
p. 1166-1172
|
artikel
|
| 196 |
The Use of Time Step Simulations and Difference Equations (TSSADEQ) in Modeling Heparin Pharmacokinetics
|
Wachsman, M.
|
|
2000
|
|
10 |
p. 1121-1128
|
artikel
|
| 197 |
The Utility of Pharmacokinetics to the Pharmaceutical Industry
|
Nelson, Robert L.
|
|
1976
|
|
10 |
p. 565-569
|
artikel
|
| 198 |
Transient Hypotensive Effect of Phenytoin in Man
|
Sullivan, Jay M.
|
|
1977
|
|
10 |
p. 607-611
|
artikel
|
| 199 |
Trimethoprim/Sulfamethoxazole Does Not Affect the Steady-State Disposition of Indinavir
|
Sturgill, Marc G.
|
|
1999
|
|
10 |
p. 1-8
|
artikel
|
| 200 |
Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem
|
Kuti, Joseph L.
|
|
2003
|
|
10 |
p. 1116-1123
|
artikel
|
| 201 |
Variability in Free Mycophenolic Acid Exposure in Adult Liver Transplant Recipients During the Early Posttransplantation Period
|
Benichou, Anne Sophie
|
|
2010
|
|
10 |
p. 1202-1210
|
artikel
|
| 202 |
Zolpidem Pharmacokinetic Properties in Young Females: Influence of Smoking and Oral Contraceptive Use
|
Olubodun, Joel O.
|
|
2002
|
|
10 |
p. 1142-1146
|
artikel
|
Tijdschrift beschrijving